Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Aug 2, 2012 · 10-Q · 33 days after period end · 0001062822-12-000037
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $199.00K | $555.00K | $1.23M |
| Net Income | -$25.93M | -$26.64M | -$25.19M |
| EPS Diluted | -$0.05 | -$0.08 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 2, 2012 · 33 d after period end
